前田 陽平 まえだ ようへい 先生

来歴等

略歴

2005年 大阪大学医学部医学科 卒業
2007年 大阪大学医学部附属病院 耳鼻咽喉科
2012年 大阪大学大学院医学系研究科 博士課程
2016年 大阪大学大学院医学系研究科 耳鼻咽喉科・頭頸部外科学 助教
2022年 地域医療機能推進機構 大阪病院 耳鼻いんこう科 部長
2024年 地域医療機能推進機構 大阪病院 院長特任補佐（兼任）

論文

• 1. 鼻科手術の最適化〜適応とアプローチ〜 好酸球性副鼻腔炎の治療方針 手術を中心に 頭頸部外科（1349-581X）32巻3号 Page203-206（2023.02）

  前田 陽平

• 2. 【コロナ時代の新たな耳鼻咽喉科診療】コロナ時代の新たな耳鼻咽喉科臨床 鼻科診療 JOHNS（0910-6820）39巻1号 Page56-58（2023.01）

  前田 陽平

• 3. 好酸球性副鼻腔炎の取り扱い Allos Ergon （2436-3820）1巻2号 Page190-197（2021.09）

  前田 陽平

• 4. 内視鏡下鼻副鼻腔手術の適応拡大 眼窩 日本耳鼻咽喉科学会会報 （0030-6622）124巻6号 Page840-848（2021.06）

  前田 陽平, 端山 昌樹, 猪原 秀典

• 5. 【術前画像と術中解剖-カンファレンスで突っ込まれないための知識】鼻副鼻腔領域 慢性副鼻腔炎に対する手術 前頭洞手術 耳鼻咽喉科・頭頸部外科 （0914-3491）93巻5号 Page104-110（2021.04）

  前田 陽平, 端山 昌樹

• 6. 【内視鏡下鼻副鼻腔手術-エキスパートに学ぶスタンダードな手術手技】上顎洞手術 ESSとEMMMによる上顎洞へのアプローチ 耳鼻咽喉科・頭頸部外科 （0914-3491）91巻9号 Page729-732（2019.08）

  前田 陽平, 端山 昌樹

• 7. アレルギー性真菌性鼻副鼻腔炎8症例の臨床的検討および本邦症例の解析 日本耳鼻咽喉科学会会報120 巻 （2017） 12 号 p. 1457-1466

  中谷 彩香, 前田 陽平, 端山 昌樹, 識名 崇, 小幡 翔, 武田 和也, 津田 武, 猪原 秀典

• 8. An innovative reconstruction procedure for fractures extending to the posterior orbital floor: utilizing the inferior margin of the greater wing of the sphenoid bone for reconstruction. Eur Arch Otorhinolaryngol. 2024 Nov;281（11）:5807-5814.

  Takabayashi K, Maeda Y （Corresponding Author）, Kataoka N.

• 9. The Endoscopic Removal of a Detached Dental Implant Cap in the Maxillary Sinus During the Waiting Period: A Case Report. Cureus. 2024 Jun 26;16（6）:e63243.

  Amano K, Nishizawa C, Maeda Y, Tanaka S, Iida S.

• 10. Neurectomy for allergic rhinitis in Japan: Increasing trends and surgeon preferences. Auris Nasus Larynx. 2024 Oct;51（5）:834-839.

  Makihara S, Hosoya K, Uraguchi K, Maeda Y, Komachi T, Yorifuji T, Ando M, Matsune S, Okubo K.

• 11. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist's integral role. Auris Nasus Larynx. 2024 Apr;51（2）:305-312.

  Hayama M, Maeda Y, Obata S, Tsuda T, Takeda K, Nishida T, Inohara H.

• 12. Modified procedure for reconstructing the inferomedial orbital wall: silicone sheet implantation without surgical removal. Eur Arch Otorhinolaryngol. 2024 Jan;281（1）:515-521.

  Takabayashi K, Maeda Y （Corresponding Author）, Kataoka N.

• 13. AQUACEL® Ag Advantage reduces the stress of postoperative packing removal after endoscopic sinus surgery. Braz J Otorhinolaryngol. 2023 Sep-Oct;89（5）:101292.

  Hosoya K, Maeda Y （Corresponding Author）, Komachi T, Sato K, Okubo K.

• 14. Evaluation of odor recognition threshold measurement methods in T&T olfactometry: A survey study. Auris Nasus Larynx. 2024 Feb;51（1）:61-68.

  Hosoya K, Komachi T, Maeda Y, Akazawa H, Ogino E, Yoshida A, Okubo K, Miwa T.

• 15. Percutaneous Transluminal Angioplasty and Stenting for Progressive Intracranial Carotid Artery Stenosis Secondary to Invasive Sphenoid Sinus Aspergillosis: A Case Report. NMC Case Rep J. 2023 Jul 13;10:215-220.

  Terada E, Nishida T, Fujita Y, Maeda Y, Hayama M, Takagaki M, Nakamura H, Oshino S, Saitoh Y, Kishima H.

• 16. S100A8 enhances IL-1β production from nasal epithelial cells in eosinophilic chronic rhinosinusitis. Allergol Int. 2023 Jan;72（1）:143-150.

  Nakatani A, Tsuda T, Maeda Y, Hayama M, Okuzaki D, Obata S, Kishikawa T, Takeda K, Inohara H.

• 17. Modified procedure for reconstructing the inferior wall of the orbit: identification of a reliable new landmark. Eur Arch Otorhinolaryngol. 2022 Dec;279（12）:5955-5961.

  Takabayashi K, Maeda Y （Corresponding Author）, Kataoka N.

• 18. Local production of broadly cross-reactive IgE against multiple fungal cell wall polysaccharides in patients with allergic fungal rhinosinusitis. Allergy. 2022 Oct;77（10）:3147-3151.

  Haruna S, Takeda K, El-Hussien MA, Maeda Y, Hayama M, Shikina T, Doi K, Inohara H, Kikutani H, Sakakibara S.

• 19. Organized Hematoma after Intra-Arterial Chemoradiotherapy for Maxillary Sinus Cancer: A Case Report. Ear Nose Throat J. 2025 Jan;104（1）:NP15-NP19.

  Tanida M, Hayama M, Maeda Y, Obata S, Nakatani A, Amano Y, Inohara H.

• 20. A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter. J Allergy Clin Immunol Pract. 2022 Jan;10（1）:355.

  Maeda Y （Corresponding Author）, Yoshioka T, Hayama M, Inohara H.

• 21. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan. Auris Nasus Larynx 2021 Nov 29:S0385-8146（21）00265-0.

  Hayama M, Maeda Y, Shikina T, Tatehara S, Inokuchi G, Hoag JB, Sato T, Obata S, Nakatani A, Amano Y, Hida E, Nibu KI, Inohara H.

• 22. A new combined approach to lost medial rectus muscle retrieval using the endoscopic transnasal approach, transcutaneous medial orbitotomy, and the sub-Tenon approach. Braz J Otorhinolaryngol. 2021 Oct 12:S1808-8694（21）00149-X.

  Takabayashi K, Maeda Y （Corresponding Author）, Kagokawa H, Nagamine M, Kataoka N, Ota I, Fujita T.

• 23. Trends in Bone Marrow Donor Registration in Japan Following a Celebrity's Disclosure of Leukemia. JAMA Netw Open. 2021 Jul 1;4（7）:e2118698.

  Yoshioka T, Tabuchi T, Maeda Y, Tsugawa Y.

• 24. Isolated sphenoid sinus opacification is often asymptomatic and is not referred for otolaryngology consultation. Sci Rep. 2021 Jun 7;11（1）:11902.

  Ashida N*, Maeda Y* （Corresponding Author）, Kitamura T, Hayama M, Tsuda T, Nakatani A, Obata S, Takeda K, Akazawa H, Inaba F, Hosomi N, Uno A, Inohara H.

• 25. Skull Base Metastasis of Breast Cancer With Oculomotor and Trochlear Nerve Palsy. Ear Nose Throat J. 2020 Oct 9:145561320963676.

  Adachi K*, Maeda Y* （Corresponding Author）, Hayama M, Kitaguchi Y, Nojima S, Nitta K, Obata S, Nakatani A, Tsuda T, Takeda K, Morii E, Inohara H.

• 26. An Unusual Case of Maxillary Sinus Cholesterol Granuloma Showing FDG Uptake on PET/CT. Clin Nucl Med. 2021 Feb 1;46（2）:e131-e132.

  Umeda N, Hayama M, Nakamura A, Maeda Y, Inohara H.

• 27. Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis. FEBS Open Bio. 2020 Sep 22;10（11）:2427-36.

  Nojima Y, Takeda Y, Maeda Y, Bamba T, Fukusaki E, Itoh MN, Mizuguchi K, Kumanogoh A.

• 28. Experience with online lectures about endoscopic sinus surgery using a video conferencing app. Auris Nasus Larynx. 2020 Dec;47（6）:1083-1085.

  Maeda Y （Corresponding Author）, Takeda K, Hayama M, Tsuda T, Shikina T, Nishiike S, Kawashima K, Inohara H.

• 29. A Case of Endonasal Endoscopic Surgery for Intraorbital Metastasis of Gastric Ring Cell Carcinoma. Ear Nose Throat J. 2020 Jul 22:145561320943372. Online ahead of print.

  Tsuruta Y*, Maeda Y* （Corresponding Author）, Kitaguchi Y, Hayama M, Nojima S, Tsuda T, Takeda K, Nakatani A, Obata S, Morii E, Inohara H.

• 30. Efficacy of the Endoscopic Triportal Transmaxillary Approach for Treating Lateral Middle Skull Base Tumors: A Technical Note and Retrospective Case Series. World Neurosurg. 2020 Oct;142:303-311.

  Umehara T, Kinoshita M, Hayama M, Shikina T, Fujimoto Y, Yohei M, Inohara H, Kishima H.

• 31. COVID-19 Stigma Induced by Local Government and Media Reporting in Japan: It's Time to Reconsider Risk Communication Lessons From the Fukushima Daiichi Nuclear Disaster. J Epidemiol. 2020 Aug 5;30（8）:372-373.

  Yoshioka T, Maeda Y.

• 32. Pathological and therapeutic implications of eosinophil-derived semaphorin 4D in eosinophilic chronic rhinosinusitis. J Allergy Clin Immunol. 2020 Mar;145（3）:843-854.e4.

  Tsuda T, Nishide M, Maeda Y, Hayama Y, Koyama S, Nojima S, Takamatsu H, Okuzaki D, Morita T, Nakatani T, Kato Y, Nakanishi Y, Futami Y, Suga Y, Naito Y, Konaka H, Satoh S, Naito M, Izumi M, Obata S, Nakatani A, Shikina T, Takeda K, Hayama M, Inohara H, Kumanogoh A.

• 33. SEMA4A promotes eosinophil survival and contributes to eosinophil-mediated allergic diseases. Allergol Int. 2019.Apr;68（2）:274-276.

  Maeda Y, Tsuda T, Takeda Y, Koyama S, Hayama Y, Nojima S, Kimura T, Ito D, Takamatsu H, Kang S, Nishide M, Morimoto K, Hosokawa T, Kinehara Y, Kato Y, Nakatani T, Takeda K, Hayama M, Obata S, Akazawa H, Shikina T, Inohara H, Kumanogoh A.

• 34. Eosinophil-derived neurotoxin enhances airway remodeling in eosinophilic chronic rhinosinusitis and correlates with disease severity. Int Immunol. 2019 Feb 6;31（1）:33-40.

  Tsuda T, Maeda Y, Nishide M, Koyama S, Hayama Y, Nojima S, Takamatsu H, Okuzaki D, Kinehara Y, Kato Y, Nakatani T, Obata S, Akazawa H, Shikina T, Takeda K, Hayama M, Inohara H, Kumanogoh A.

• 35. Allergic conversion of protective mucosal immunity against nasal bacteria in patients with chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2019 Mar;143（3）:1163-1175.e15.

  Takeda K, Sakakibara S, Yamashita K, Motooka D, Nakamura S, El Hussien MA, Katayama J, Maeda Y, Nakata M, Hamada S, Standley DM, Hayama M, Shikina T, Inohara H, Kikutani H.

• 36. Lysosomal Protein Lamtor1 Controls Innate Immune Responses via Nuclear Translocation of Transcription Factor EB. J Immunol. 2018 Jun 1;200（11）:3790-3800.

  Hayama Y, Kimura T, Takeda Y, Nada S, Koyama S, Takamatsu H, Kang S, Ito D, Maeda Y, Nishide M, Nojima S, Sarashina-Kida H, Hosokawa T, Kinehara Y, Kato Y, Nakatani T, Nakanishi Y, Tsuda T, Koba T, Okada M, Kumanogoh A.

• 37. Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging. Sci Rep. 2018 Mar 23;8（1）:

  Jin Y, Takeda Y, Kondo Y, Tripathi LP, Kang S, Takeshita H, Kuhara H, Maeda Y, Higashiguchi M, Miyake K, Morimura O, Koba T, Hayama Y, Koyama S, Nakanishi K, Iwasaki T, Tetsumoto S, Tsujino K, Kuroyama M, Iwahori K, Hirata H, Takimoto T, Suzuki M, Nagatomo I, Sugimoto K, Fujii Y, Kida H, Mizuguchi K, Ito M, Kijima T, Rakugi H, Mekada E, Tachibana I, Kumanogoh A.

• 38. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals. Nat Commun. 2016 Oct 12;7:13130.

  Kimura T, Nada S, Takegahara N, Okuno T, Nojima S, Kang S, Ito D, Morimoto K, Hosokawa T, Hayama Y, Mitsui Y, Sakurai N, Sarashina-Kida H, Nishide M, Maeda Y, Takamatsu H, Okuzaki D, Yamada M, Okada M, Kumanogoh A.

• 39. LRRK1 is critical in the regulation of B-cell responses and CARMA1-dependent NF-κB activation. Sci Rep. 2016 May 11;6:25738.

  Morimoto K, Baba Y, Shinohara H, Kang S, Nojima S, Kimura T, Ito D, Yoshida Y, Maeda Y, Sarashina-Kida H, Nishide M, Hosokawa T, Kato Y, Hayama Y, Kinehara Y, Okuno T, Takamatsu H, Hirano T, Shima Y, Narazaki M, Kurosaki T, Toyofuku T, Kumanogoh A.

• 40. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells. J Immunol. 2015 Aug 1;195（3）:934-43.

  Ito D, Nojima S, Nishide M, Okuno T, Takamatsu H, Kang S, Kimura T, Yoshida Y, Morimoto K, Maeda Y, Hosokawa T, Toyofuku T, Ohshima J, Kamimura D, Yamamoto M, Murakami M, Morii E, Rakugi H, Isaka Y, Kumanogoh A.

• 41. Validation of noninvasive morphological and diffusion imaging in mouse emphysema by micro-computed tomography and hyperpolarized （129）Xe magnetic resonance imaging. Am J Respir Cell Mol Biol. 2013 Oct;49（4）:592-600.

  Tetsumoto S, Takeda Y, Imai H, Kimura A, Jin Y, Nakanishi K, Maeda Y, Kuhara H, Tsujino K, Iwasaki T, Shigeta H, Kondo Y, Ito M, Minami T, Hirata H, Takahashi R, Kohmo S, Nagatomo I, Inoue K, Kida H, Kijima T, Tachibana I, Maeda N, Funahashi T, Shimomura I, Fujiwara H, Kumanogoh A.

• 42. A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration. Nat Commun. 2013;4:1406.

  Nojima S, Toyofuku T, Kamao H, Ishigami C, Kaneko J, Okuno T, Takamatsu H, Ito D, Kang S, Kimura T, Yoshida Y, Morimoto K, Maeda Y, Ogata A, Ikawa M, Morii E, Aozasa K, Takagi J, Takahashi M, Kumanogoh A.

• 43. An inhibitory role for Sema4A in antigen-specific allergic asthma. J Clin Immunol. 2013 Jan;33（1）:200-9.

  Morihana T, Goya S, Mizui M, Yasui T, Prasad DV, Kumanogoh A, Tamura M, Shikina T, Maeda Y, Iwamoto Y, Inohara H, Kikutani H.

SNS・ブログ等

• その他メディア
  • 【YouTube】日本耳鼻咽喉科頭頸部外科学会 公式チャンネル